%0 Journal Article
%A 
%T Comparison of FOLFIRI and Paclitaxel as Second-Line Chemotherapy in Metastatic HER2-Negative Gastric Cancer: A Real-World Retrospective Analysis
%D 2026
%F 
%P 345-358
%V 10
%N 3
%R doi:10.14744/ejmi.269345
%U https://dx.doi.org/10.14744/ejmi.269345